Condire Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Condire Management’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,935	Closed	-$3.06M	–	23
2021 Q1	$3.06M	Buy	+1,935	New	+$4.53M	0.91%	16

Other funds holding LABU

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UMC

United Maritime Capital New York $15.2M AUM 45.42% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Condire Management's LABU Position: Q2 2021 in Review

Condire Management sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2021, closing a stake of 1,935 shares — an estimated $3.06M sold.

Condire Management first reported a position in LABU in Q1 2021 and held it in 1 quarter. The position peaked at $3.06M in Q1 2021. 24 funds tracked by Wall St. Rank hold LABU as of Q2 2021.

Condire Management reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2021 after selling out during the quarter.
Condire Management sold 1,935 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2021, an estimated $3.06M.
Condire Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2021 and held it in 1 quarter.
Condire Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $3.06M in Q1 2021.
24 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2021.

Based on Condire Management's 13F filing for Q2 2021, filed 16 Aug 2021.